Chinese Severe Brain Injury Trial
CSBIT
1 other identifier
observational
3,000
0 countries
N/A
Brief Summary
Building a Large Chinese Cohort(Chinese Severe brain injury Trial)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2023
CompletedFirst Posted
Study publicly available on registry
December 22, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
December 22, 2023
December 1, 2023
3 years
December 10, 2023
December 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Glasgow Outcome Scale
The unabbreviated scale title is Glasgow Outcome Scale. GOS includes a score of 1-5, with the higher the score, the better the prognosis.
6 months after severe Brain Injury
Secondary Outcomes (1)
Glasgow Outcome Scale
3 months and 12 months after severe Brain Injury
Study Arms (2)
good prognosis group
poor prognosis group
Eligibility Criteria
Patients with impaired consciousness with a clear cause of brain injury.
You may qualify if:
- a clear cause of brain injury
- disorders of consciousness, GCS≤12
- within six months of onset
You may not qualify if:
- not applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2023
First Posted
December 22, 2023
Study Start
January 1, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
December 22, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share